153 related articles for article (PubMed ID: 1977666)
21. Sialyl Lewis-Xi antigen in patients with gynecologic tumors.
Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saito J; Tanizawa O
Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045
[TBL] [Abstract][Full Text] [Related]
22. Differential diagnosis of ovarian cancer, benign ovarian tumor and endometriosis by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels.
Iwanari O; Miyako J; Date Y; Nakayama S; Kijima S; Moriyama M; Takahashi K; Yoshino N; Karino K; Endoh J
Gynecol Obstet Invest; 1990; 29(1):71-4. PubMed ID: 1972127
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.
Scambia G; Benedetti Panici P; Perrone L; Sonsini C; Giannelli S; Gallo A; Natali PG; Mancuso S
Br J Cancer; 1990 Jul; 62(1):147-51. PubMed ID: 2167724
[TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of serum sialyl SSEA-1 (SLX) in diagnosis of cancers].
Kawakami H; Sawabu N; Takemori Y; Okai T; Motoo Y; Satomura Y; Ohta H; Watanabe H; Matsuda N; Yamakawa O
Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1141-8. PubMed ID: 2571740
[TBL] [Abstract][Full Text] [Related]
25. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
[TBL] [Abstract][Full Text] [Related]
26. [Expression of blood group-related antigens Lewis A, Lewis B, CA 19-9, and sialyl SSEA-1 in normal human skin in comparison with the patient's blood type].
Hirai S; Kageshita T; Nakamura T; Yoshii A; Kimura T; Arao T
Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):115-20. PubMed ID: 1677054
[TBL] [Abstract][Full Text] [Related]
27. Sialyl SSEA-1 antigen as a carbohydrate marker of human natural killer cells and immature lymphoid cells.
Ohmori K; Yoneda T; Ishihara G; Shigeta K; Hirashima K; Kanai M; Itai S; Sasaoki T; Arii S; Arita H
Blood; 1989 Jul; 74(1):255-61. PubMed ID: 2568858
[TBL] [Abstract][Full Text] [Related]
28. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1992 Jan; 10(1):95-101. PubMed ID: 1727929
[TBL] [Abstract][Full Text] [Related]
29. [Clinical usefulness of tumor markers associated with pancreatic cancer].
Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
[TBL] [Abstract][Full Text] [Related]
30. Elevation of sialyl stage-specific mouse embryonic antigen levels in pleural effusion in patients with adenocarcinoma of the lung.
Iguchi H; Hara N; Miyazaki K; Ohtsu Y; Sonoda F; Ohta M
Cancer; 1989 Apr; 63(7):1327-30. PubMed ID: 2563956
[TBL] [Abstract][Full Text] [Related]
31. [Determination of various tumor markers, with special reference to sialyl SSEA-1 antigen in lung cancer].
Satoh H; Yano H; Naitoh T; Takahashi N; Suyama T; Murayama J; Kameyama M; Fukuda K; Satoh T; Ohtsuka M
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2917-22. PubMed ID: 2902833
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].
Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400
[TBL] [Abstract][Full Text] [Related]
33. CA 15-3 serum levels in ovarian cancer.
Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
[TBL] [Abstract][Full Text] [Related]
34. The effect of non-insulin-dependent diabetes on serum concentrations of tumor-associated carbohydrate antigens of CA19-9, CA-50, and sialyl SSEA-1 in association with the Lewis blood phenotype.
Shimojo N; Naka K; Nakajima C; Ishizaki T; Okuda K; Murai J; Yamamoto M
Clin Chim Acta; 1990 Oct; 190(3):283-9. PubMed ID: 1979260
[TBL] [Abstract][Full Text] [Related]
35. Expression of Lewis-related antigen and prognosis in stage I non-small cell lung cancer.
Ogawa J; Sano A; Inoue H; Koide S
Ann Thorac Surg; 1995 Feb; 59(2):412-5. PubMed ID: 7847958
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2.
Kawa S; Kato M; Oguchi H; Hsue GL; Kobayashi T; Koiwai T; Tokoo M; Furuta S; Ichikawa T; Kanai M
Scand J Gastroenterol; 1992 Aug; 27(8):635-43. PubMed ID: 1359630
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
[TBL] [Abstract][Full Text] [Related]
38. Tn and sialyl-Tn antigens as potential prognostic markers in human ovarian carcinoma.
Ogawa H; Ghazizadeh M; Araki T
Gynecol Obstet Invest; 1996; 41(4):278-83. PubMed ID: 8793500
[TBL] [Abstract][Full Text] [Related]
39. [Serum sialyl Tn antigen as a prognostic marker in patients with epithelial ovarian cancer].
Kobayashi H; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):14-20. PubMed ID: 1541859
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker.
Onetto M; Bruzzone M; Conte PF; Ruvolo M; Conio A; Chiara S; Falcone A; Bentivoglio G; Serra GE; Paganuzzi M
Oncology; 1989; 46(2):117-22. PubMed ID: 2710476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
